Mindy Simpson to Hemorrhage
This is a "connection" page, showing publications Mindy Simpson has written about Hemorrhage.
Connection Strength
3.143
-
Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis. Thromb Haemost. 2021 08; 121(8):1079-1086.
Score: 0.715
-
A Real-World Analysis of Commonly Prescribed FVIII Products Based on U.S. Medical Charts: Consumption and Bleeding Outcomes in Hemophilia A Patients. J Manag Care Spec Pharm. 2020 Oct; 26(10):1258-1265.
Score: 0.701
-
Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY?94-9027 for Severe Haemophilia?A: A Post Hoc Analysis. Adv Ther. 2020 06; 37(6):2763-2776.
Score: 0.687
-
Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products. J Manag Care Spec Pharm. 2020 Apr; 26(4):504-512.
Score: 0.675
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.142
-
Use of global assays to understand clinical phenotype in congenital factor VII deficiency. Haemophilia. 2013 Sep; 19(5):765-72.
Score: 0.106
-
Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A. Haemophilia. 2023 Sep; 29(5):1234-1242.
Score: 0.054
-
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. N Engl J Med. 2016 May 26; 374(21):2054-64.
Score: 0.033
-
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the?Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015 Sep; 13(9):1597-605.
Score: 0.031